All episodes
The Last Major Disease To Be Studied? Ron Davis of Stanford Thinks So
On Bioinformatics Data Sharing and Collaboration: Andrew Carroll, DNAnexus
Grail Merger, Genomic Autopsies, Overtreatment Alarm, and Controversy at Ancestry.com: May 2017 Review with Nathan and Laura
Is Population Medicine Failing Us? Michel Accad
Deep Omics Profiler, Mike Snyder, Now Turns to Wearables
Over $1 Billion Invested this Past Year: Synthetic Biology in 2017 with John Cumbers
Green Light for DTC, Blood Mammograms, and Ancient DNA: April 2017 with Nathan and Laura
With 50 Million Users, Is Academia.edu Speeding Up Science?
How to Improve Lab Tests in the Absence of FDA Regulation?
Known for Medical Devices, 116 Yr Old BD Makes a Bold Move in Genomics
Proposed NIH Cuts, Undermining GINA, and Game Changing Drugs: March 2017 with Nathan and Laura
Art in the Lab (Falling in Love with Bacteria)
Flint Whistleblower Says Today's Science Is to Blame for Its Own Lack of Public Trust
The Story of Geisinger and Doing Genomic Medicine at the Right Pace
In-Situ Sequencing, CRISPR Patents, and Racist Milk Drinkers: February 2017 with Nathan and Laura
New Pocket Size Nanopore Device Could Revolutionize Diagnostic and Other Testing
By Changing a Basic Lab Step, Acoustic Liquid Transfer Having a Broad Impact
Many Biologists Today Don’t Have Enough Computer Science to Use the Databases
Cardiologists Love Genomics: Euan Ashley, Stanford
Scientists vs Trump: January 2017 with Nathan and Laura
Want to Stop Smoking? Start with Epigenetic Biomarker that Tells Doc the Truth
When an Exome Test Is Part of the Therapy and Not a Diagnostic: John West on Personalis and Personalized Cancer Vaccines
People Told Us It Was Impossible: UCSC’s Mark Akeson on Nanopore Sequencing
When Long Reads are Double the Price of Short Reads, Short Reads Are Dead, Says Evan Eichler
Genomics in 2016: Nathan and Laura Name Their Top Stories
Hank Greely on “The End of Sex" and Other Stuff
How to Scale Cancer Genomics, with Marco Marra, UBC
What Does the Election Mean for Genomics? November 2016 with Nathan and Laura
The Saga Continues: Ethan Perlstein, Indie Scientist, Part 3
Biomarker Panel to Predict Type 1 Diabetes
Can You Name the World’s Largest Single Disease Research Charity?
Why Diversity Is the Only Path Forward: Sarah Tishkoff on African Genomics
October 2016 with Nathan and Laura
We’re Over Halfway There: Baylor's Richard Gibbs on Clinical Genetics
With FDA Guidance on LDTs Still Not Out, What Are Labs Doing?
Reference Genome Making Major Strides in Ethnic Diversity, Says Valerie Schneider, NCBI
September 2016 with Nathan and Laura
Luke Timmerman on His New Biography of Lee Hood
How Personalized is Personalized Medicine? Krister Wennerberg on FIMM’s Individualized Systems Medicine
Digital PCR Opens Up New Liquid Biopsy Opportunity in Melanoma Treatment: David Polsky, NYU
Erica Ramos on Her Pioneering Role as Genetic Counselor for Industry
August 2016 with Nathan and Laura
A Maniacal Commitment to Science: Peering into Regeneron’s Genetics Center with Jeff Reid
The Days of Miracle and Wonder: Laura Hercher on Genetic Counseling, Part 2
The Days of Miracle and Wonder: Laura Hercher on Genetic Counseling, Part 1
A Precision Medicine Platform Comes of Age: Jonathan Hirsch, Syapse
FDA’s Liz Mansfield on New NGS Guidances
How Is the Brexit Impacting Genomics? with Clare Turnbull and Hadyn Parry
It’s Not Really Bulls and Bears: John Carroll on His New Gig, the Brexit, and a New Metaphor for the Market
June 2016 with Nathan and Laura: GMO Labeling, Misspelling CRISPR, Sequenom Patent Loss, SmidgIon
Know Then Thyself: Kari Stefansson, deCODE genetics
Sequenom Patent Loss a Threat to Personalized Medicine, Says Kevin Noonan
Bringing Home Some Diagnostics Gold: Brad Gray, NanoString Show How It’s Done
Mukherjee Mess-up, the Secret Harvard Meeting, and Success in Gene Therapy: May 2016 with Nathan and Laura
When Do We Move to Population Based Cancer Screening for Those with High Genetic Risk? Josh Schiffman, U of U
The Solid Future of Liquid Biopsies with Michael Nall, Biocept
Genomics Is Oversubscribed, Says Creator of BLAST
With 10K Genomes Sequenced, Genomics England in High Gear: Clare Turnbull, Clinical Lead
April 2016 with Nathan and Laura: Big Money, More CRISPR Studies, Genomic Superheroes, and a Pot Chaser
A Sneak Peek into the Future of Clinical Genomics with Ben Solomon, Inova
Preprints and the Future of Science Publishing with Jason Hoyt, PeerJ
Flipping Drug Development Upside Down: Niven Narain, BERG Health
March 2016 with Nathan and Laura: Genomic Jenga and the Creator, the Anti-Abortion Lobby and Genetic Testing, and Theranos, Again
Medicine and the Limits of Science with Michel Accad, MD
How Good are Linked Reads? Serge Saxonov, 10X Genomics
A Home Run on the First Hit: PacBio’s Jonas Korlach
Digital Pathology at Scale: Epic Sciences Takes CTC Technology to the Next Level
February 2016: Mosquitos, Preprints, and that Rocking White House Summit
BioNano Genomics Stakes Out Sequencing Territory as They Discover Lots of De Novo Variants in Reference Genome Projects
Is Oxitec Ready to Scale as Governments Seek Options to Control the Zika Virus?
Human Genome Turns 15: Mike Hunkapiller
January 2016: Landergate, Grail, and Cancer Moonshot
Frontiers of Sequencing: Putting Long Reads and Graph Assemblies to Work
Why Drugs Are Priced So High and Diagnostics So Low
Who Is John Ioannidis?
Cancer: Year in Review 2015 with Anna Barker
Sci-Fi Author Kim Stanley Robinson Talks Life Science 2015
Yes to FDA Regulation of LDTs, But We Need a New Framework, Says David Spetzler
Genomics and the Cloud Going Through “a Second Puberty,” says AWS’ Angel Pizarro
Hot Biotech Market Neglects Stem Cell Therapies, Says CIRM's Neil Littman
The Future of Diagnostics Reimbursement with Bruce Quinn
Framingham for the Modern Era: Josie Briggs on the Precision Medicine Initiative
Do Alternate Proposals to Regulate LDTs Stand a Chance?
Does the Reproducibility Project in Cancer Biology Offer a Model for a New Kind of Science Auditing?
After CMS Announcement, Peter Maag and CareDx Fight for Life
The Goal Is De Novo Assembly in the Clinic, Says Jim Lupski, Baylor
Cliff Reid Says New Supersequencer Leads the Pack for High Throughput Clinical Sequencing
Defending the Value of Biotech Innovation in California: Sara Radcliffe, CLSA
Long Read Sequencing Dramatically Improves Blood Matching: Steven Marsh, Anthony Nolan Institute
The World of DIY Genomics with K T Pickard
Sequencing in Space: Chris Mason, Cornell
Is the Future of Biology a Return to Chemistry? Carolyn Bertozzi, Stanford
Going Beyond the $1,000 Genome with Mark Gerstein
Creating the Foundation of Genomics: Marc Salit, NIST
Still Unhappy with FDA’s Plan to Regulate LDTs, Professional Lab Groups Go Direct to the Senate
A Diagnostic Success Story with Alka Chaubey, Greenwood Genetic Center
With Two New Easy-to-Use Sequencing Instruments, Thermo Readies for Primetime in the Clinic
Here's Looking at Euclid
Is This the Future of Clinical Trials for Cancer? Stanley Hamilton on the NCI’s New MATCH Trial
Brian Kennedy and Aubrey de Grey on their Converging Approaches to Aging Research